Volume 21, 2014
Innovation for the Management of Echinococcosis. Invited editors: Dominique A. Vuitton, Laurence Millon, Bruno Gottstein and Patrick Giraudoux
Article Number 74
Number of page(s) 14
Published online 23 December 2014
  1. Azizi A, Blagosklonov O, Lounis A, Berthet L, Vuitton DA, Bresson-Hadni S, Delabrousse E. 2014. Alveolar echinococcosis: correlation between hepatic MRI findings and FDG-PET/CT metabolic activity. Abdominal Imaging, 39, Jun 27 [Epub ahead of print]. [Google Scholar]
  2. Baron RW, Tanner CE. 1976. The effect of immunosuppression on secondary Echinococcus multilocularis infections in mice. International Journal for Parasitology, 6, 37–42. [CrossRef] [PubMed] [Google Scholar]
  3. Bartholomot G, Vuitton DA, Harraga S, Shi DZ, Giraudoux P, Barnish G, Wang YH, MacPherson CN, Craig PS. 2002. Combined ultrasound and serologic screening for hepatic alveolar echinococcosis in central China. American Journal of Tropical Medicine and Hygiene, 66, 23–29. [Google Scholar]
  4. Bresson-Hadni S, Delabrousse E, Blagosklonov O, Bartholomot B, Koch S, Miguet JP, Mantion GA, Vuitton DA. 2006. Imaging aspects and non-surgical interventional treatment in human alveolar echinococcosis. Parasitology International, 55, S267–S272. [CrossRef] [PubMed] [Google Scholar]
  5. Bresson-Hadni S, Grenouillet F, Knapp J, Demonmerot F, Richou C, Vuitton DA, Millon L, the FrancEchino and EchinoVista networks. 2014. Reference-centre network for the care management of alveolar echinococcosis: the FrancEchino and EchinoVista experience, in Proceedings of the international symposium “Innovation for the management of echinococcosis”, Besançon, March 27–29, 2014, Vuitton DA, Millon L, Gottstein B, Giraudoux P, Editors. Parasite, 21, 28, 63–64. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Bresson-Hadni S, Liance M, Meyer JP, Houin R, Bresson JL, Vuitton DA. 1990. Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice. Clinical and Experimental Immunology, 82, 378–383. [CrossRef] [PubMed] [Google Scholar]
  7. Bresson-Hadni S, Mantion GA, Vuitton DA. 2004. Alveolar echinococcosis in the Paris area. Gastroentérologie Clinique et Biologique, 28, 1147–1151. [CrossRef] [Google Scholar]
  8. Brunetti E, Kern P, Vuitton DA, Writing Panel for the WHO-IWGE. 2010. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Tropica, 114, 1–16. [CrossRef] [PubMed] [Google Scholar]
  9. Caoduro C, Porot C, Vuitton DA, Bresson-Hadni S, Grenouillet F, Richou C, Boulahdour H, Blagosklonov O. 2013. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis. Journal of Nuclear Medicine, 54, 358–363. [CrossRef] [Google Scholar]
  10. Chauchet A, Grenouillet F, Knapp J, Richou C, Delabrousse E, Dentan C, Millon L, Di Martino V, Contreras R, Deconinck E, Blagosklonov O, Vuitton DA, Bresson-Hadni S. 2014. Increased incidence and characteristics of alveolar echinococcosis in patients with immunosuppression-associated conditions. Clinical Infectious Diseases, 59, 1095–1104. [CrossRef] [Google Scholar]
  11. Coşkun A, Oztürk M, Karahan OI, Erdogan N, Işin S, Güleç M. 2004. Alveolar Echinococcosis of the Liver: Correlative Color Doppler US, CT, and MRI Study. Acta Radiologica, 45, 492–498. [CrossRef] [PubMed] [Google Scholar]
  12. Craig P. 2003. Echinococcus multilocularis. Current Opinion in Infectious Diseases, 16, 437–444. [CrossRef] [PubMed] [Google Scholar]
  13. Crouzet J, Grenouillet F, Delabrousse E. 2010. Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up. Clinical Microbiology and Infection, 16, 788–791. [CrossRef] [Google Scholar]
  14. Culverwell AD, Sheridan MB, Guthrie JA, Scarsbrook AF. 2013. Diffusion-weighted MRI of the liver – Interpretative pearls and pitfalls. Clinical Radiology, 68, 406–414. [CrossRef] [PubMed] [Google Scholar]
  15. Dohan A, Soyer P, Guerrache Y, Hoeffel C, Gavini JP, Kaci R, Boudiaf M. 2014. Focal nodular hyperplasia of the liver: diffusion-weighted magnetic resonance imaging characteristics using high B values. Journal of Computer Assisted Tomography, 38, 96–104. [PubMed] [Google Scholar]
  16. Eckert J, Deplazes P. 2004. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clinical Microbiology Reviews, 17, 107–135. [CrossRef] [PubMed] [Google Scholar]
  17. Ehrhardt AR, Reuter S, Buck AK, Haenle MM, Mason RA, Gabelmann A, Kern P, Kratzer W. 2007. Assessment of disease activity in alveolar echinococcosis: a comparison of contrast-enhanced ultrasound, three-phase helical CT and 18F fluoroxyglucose positron-emission tomography. Abdominal Imaging, 32, 730–736. [CrossRef] [PubMed] [Google Scholar]
  18. Fornaro J, Leschka S, Hibbeln D. 2011. Dual- and multi-energy CT: approach to functional imaging. Insights in Imaging, 2, 149–159. [CrossRef] [Google Scholar]
  19. Gottstein B, Dai WJ, Walker M, Stettler M, Müller N, Hemphill A. 2002. An intact laminated layer is important for the establishment of secondary Echinococcus multilocularis infection. Parasitology Research, 88, 822–828. [CrossRef] [PubMed] [Google Scholar]
  20. Gottstein B, Haag K, Walker M, Matsumoto J, Mejri N, Hemphill A. 2006. Molecular survival strategies of Echinococcus multilocularis in the murine host. Parasitology International, 55, 45–49. [CrossRef] [PubMed] [Google Scholar]
  21. Guerret S, Vuitton DA, Liance M, Pater C, Carbillet JP. 1998. Echinococcus multilocularis: relationship between susceptibility/resistance and liver fibrogenesis in experimental mice. Parasitology Research, 84, 657–667. [CrossRef] [PubMed] [Google Scholar]
  22. Karçaaltincaba M, Sirlin CB. 2011. CT and MRI of diffuse lobar involvement pattern in liver pathology. Diagnostic and Interventional Radiology, 17, 334–342. [Google Scholar]
  23. Kern P, Bardonnet K, Renner E, Auer H, Pawlowski Z, Ammann RW, Vuitton DA, Kern P. 2003. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982–2000. Emerging Infectious Diseases, 9, 343–349. [CrossRef] [PubMed] [Google Scholar]
  24. Kern P, Wen H, Sato N, Vuitton DA. 2006. WHO classification of alveolar echinococcosis: principles and application. Parasitology International, 55, S283–S287. [CrossRef] [PubMed] [Google Scholar]
  25. Kodama Y, Fujita N, Shimizu T. 2003. Alveolar echinococcosis: MR findings in the liver. Radiology, 228, 172–177. [CrossRef] [PubMed] [Google Scholar]
  26. Kratzer W, Reuter S, Hirschbuehl K, Ehrhardt AR, Mason RA, Haenle MM, Kern P, Gabelmann A. 2005. Comparison of contrast-enhanced power Doppler ultrasound (Levovist) and computed tomography in alveolar echinococcosis. Abdominal Imaging, 30, 286–290. [CrossRef] [PubMed] [Google Scholar]
  27. Le Moigne F, Durieux M, Bancel B, Boublay N, Boussel L, Ducerf C, Berthezène Y, Rode A. 2012. Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver. Magnetic Resonance Imaging, 30, 656–665. [CrossRef] [PubMed] [Google Scholar]
  28. Lin RY, Wang JH, Lu XM, Zhou XT, Mantion G, Wen H, Vuitton DA, Richert L. 2009. Components of the mitogen-activated protein kinase cascade are activated in hepatic cells by Echinococcus multilocularis metacestode. World Journal of Gastroenterology, 15, 2116–2124. [CrossRef] [Google Scholar]
  29. Macpherson CN, Bartholomot B, Frider B. 2003. Application of ultrasound in diagnosis, treatment, epidemiology, public health and control of Echinococcus granulosus and E. multilocularis. Parasitology, 127, 21–35. [CrossRef] [PubMed] [Google Scholar]
  30. Mileto A, Marin D, Nelson RC. 2014. Dual energy MDCT assessment of renal lesions: an overview. European Radiology, 24, 353–362. [CrossRef] [PubMed] [Google Scholar]
  31. Piarroux M, Piarroux R, Giorgi R, Knapp J, Bardonnet K, Sudre B, Watelet J, Dumortier J, Gérard A, Beytout J, Abergel A, Mantion G, Vuitton DA, Bresson-Hadni S. 2011. Clinical features and evolution of alveolar echinococcosis in France from 1982 to 2007: results of a survey in 387 patients. Journal of Hepatology, 55, 1025–1033. [CrossRef] [PubMed] [Google Scholar]
  32. Polat KY, Ozturk G, Aydinli B, Kantarci M. 2004. Images of interest. Hepatobiliary and pancreatic: alveolar hydatid disease. Journal of Gastroenterology and Hepatology, 19, 1319. [CrossRef] [PubMed] [Google Scholar]
  33. Porot C, Knapp J, Wang J, Camporese D, Germain S, Seimbille Y, Vuitton DA, Gottstein B, Blagosklonov O. 2014. Development of a specific tracer for alveolar echinococcosis metabolic imaging: a preclinical study, in Proceedings of the IEEE Engineering in Medicine and Biology Society Annual Meeting IEEE: Chicago. p. 5587–5590, [Google Scholar]
  34. Ren B, Wang J, Liu W. 2012. Comparative study between diffusion weighted imaging and histopathological features in hepatic alveolar echinococcosis. Chinese Journal of Radiology, 46, 57–61. [Google Scholar]
  35. Reuter S, Buck A, Manfras B, Kratzer W, Seitz HM, Darge K, Reske SN, Kern P. 2004. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology, 39, 509–517. [CrossRef] [PubMed] [Google Scholar]
  36. Reuter S, Grüner B, Buck AK, Blumstein N, Kern P, Reske SN. 2008. Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET. Nuklearmedizin, 47, 147–152. [PubMed] [Google Scholar]
  37. Reuter S, Schirrmeister H, Kratzer W. 1999. Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography. Clinical Infectious Diseases, 29, 1157–1163. [CrossRef] [Google Scholar]
  38. Sandrasegaran K, Tahir B, Nutakki K, Akisik FM, Bodanapally U, Tann M, Chalasani N. 2013. Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients. American Journal of Roentgenology, 201, 1211–1219. [CrossRef] [Google Scholar]
  39. Scharf G, Deplazes P, Kaser-Hotz B. 2004. Radiographic, ultrasonographic, and computed tomographic appearance of alveolar echinococcosis in dogs. Veterinary Radiology and Ultrasound, 45, 411–418. [CrossRef] [Google Scholar]
  40. Stumpe KD, Renner-Schneiter EC, Kuenzle AK. 2007. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy. Infection, 35, 11–18. [CrossRef] [PubMed] [Google Scholar]
  41. Suzuki Y, Fujimoto Y, Hosoki Y, Suzuki M, Inoue M, Sakurai S, Ohtake T, Ohhira M, Saito H, Kohgo Y. 2003. Usefulness of contrast-enhanced wide-band Doppler ultrasonography to diagnose alveolar echinococcosis of the liver and evaluate the effect of the treatment. European Journal of Radiology, 48, 305–311. [CrossRef] [PubMed] [Google Scholar]
  42. Tao S, Qin Z, Hao W, Yongquan L, Lanhui Y, Lei Y. 2011. Usefulness of gray-scale contrast-enhanced ultrasonography in diagnosing hepatic alveolar echinococcosis. Ultrasound in Medicine and Biology, 37, 1024–1028. [CrossRef] [Google Scholar]
  43. Türkbey B, Aras O, Karabulut N. 2012. Diffusion-weighted MRI for detecting and monitoring cancer: a review of current applications in body imaging. Diagnostic and Interventional Radiology, 18, 46–59. [Google Scholar]
  44. Vuitton DA, Bresson-Hadni S. 2014. Alveolar echinococcosis: evaluation of the therapeutic strategies. Expert Opinion on Orphan Drugs, 2, 67–86. [CrossRef] [Google Scholar]
  45. Vuitton DA, Bresson-Hadni S, Laroche L. 1989. Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis. Clinical and Experimental Immunology, 78, 67–74. [PubMed] [Google Scholar]
  46. Vuitton DA, Guerret-Stocker S, Carbillet JP, Mantion G, Miguet JP, Grimaud JA. 1986. Collagen immunotyping of the hepatic fibrosis in human alveolar echinococcosis. Zeitschrift für Parasitenkunde, 72, 97–104. [CrossRef] [Google Scholar]
  47. Vuitton DA, Zhou H, Bresson-Hadni S. 2003. Epidemiology of alveolar echinococcosis with particular reference to China and Europe. Parasitology, 127, S87–S107. [CrossRef] [PubMed] [Google Scholar]
  48. Wang J, Lin R, Zhang W, Li L, Gottstein B, Blagosklonov O, Lü G, Zhang C, Lu X, Vuitton DA, Wen H. 2014. Transcriptional profiles of cytokine/chemokine factors of immune cell-homing to the parasitic lesions: a comprehensive one-year course study in the liver of E. multilocularis-infected mice. PLoS One, 17, e91638. [CrossRef] [PubMed] [Google Scholar]
  49. Wang J, Ren B, Liu W. 2011. Correspondence Analysis between perfusion CT and microvessel density, vascular endothelial growth factor in hepatic alveolar echinococcus. Chinese Journal of Radiology, 45, 1036–1039. [Google Scholar]
  50. Weiner SM, Krenn V, Koelbel C, Hoffmann HG, Hinkeldey K, Ockert D. 2011. Echinococcus multilocularis infection and TNF inhibitor treatment in a patient with rheumatoid arthritis. Rheumatology International, 31, 1399–1400. [CrossRef] [PubMed] [Google Scholar]
  51. Xie W, Wang J, Liu W. 2012. The correlation between ADC and the area of fibrosis in border of hepatic alveolar echinococcosis. Journal of Practical Diagnosis and Therapy, 26, 467–470. [Google Scholar]
  52. Zeng H, Wang J, Xie W, Liu W, Wen H. 2012. Assessment of early hepatic Echinococcus multilocularis infection in rats with real-time contrast-enhanced ultrasonography. Ultrasound in Medicine and Biology, 38, 1982–1988. [CrossRef] [Google Scholar]
  53. Zhang C, Wang J, Lü G, Li J, Lu X, Mantion G, Vuitton DA, Wen H, Lin R. 2012. Hepatocyte proliferation/growth arrest balance in the liver of mice during E. multilocularis infection: a coordinated 3-stage course. PLoS One, 7, e30127. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.